Izvoz spreman — 

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

BACKGROUND AND OBJECTIVE: Indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily (q.d.) has demonstrated greater improvements in lung function, patient‐reported outcomes and lower exacerbation rates versus mono long‐acting muscarinic antagonists (LAMA) in chronic obstructive pulmonary disease (CO...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respirology
Glavni autori: Muro, Shigeo, Yoshisue, Hajime, Kostikas, Konstantinos, Olsson, Petter, Gupta, Pritam, Wedzicha, Jadwiga A.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2019
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155057/
https://ncbi.nlm.nih.gov/pubmed/31339215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.13651
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items